Nature Reviews Cardiology

Nature Reviews Cardiology (commonly abbreviated as ''Nat. Rev. Cardiol.') is a cardiovascular review journal published by Springer Nature. It was founded in 2004 as Nature Clinical Practice Cardiovascular Medicine and took its present title in April 2009, with a 2025 impact factor of 50.2.Nature Reviews Cardiology（常用缩写 Nat. Rev. Cardiol.）是 Springer Nature 旗下心血管领域的综述类期刊，2004 年以 Nature Clinical Practice Cardiovascular Medicine 之名创刊，2009 年 4 月改为现名，2025 年影响因子为 50.2。^[1]

Scope

• Disciplinary focus: clinical, translational and basic science content is written by internationally renowned clinicians, academics and researchers, and the journal aims to be the premier source of reviews and commentaries for the scientific and clinical communities it serves, publishing articles that are authoritative, accessible and enhanced with clearly understandable display items.学科定位： 期刊的临床、转化与基础科学内容由国际知名的临床医生、学者与研究者撰写，目标是成为所服务科学界与临床界在综述与评论方面的首要来源，所载文章力求权威、易读并配有清晰易懂的图表与展示材料；
• Audience: the content is intended for practising doctors and research scientists working in the cardiovascular field, while the journal aims to make all its articles accessible to readers working in any biological or medical discipline, from postgraduate level upwards.读者对象： 主要供心血管领域的执业医师与科研人员阅读，同时力求让任何生物或医学学科的读者都能读懂其文章，读者定位自研究生层次起算；
• Content types: in-depth narrative Reviews present authoritative and up-to-date information on a topic, placing it in the context of the history and development of the field. Consensus Statements, Evidence-based Guidelines, Expert Recommendations and Roadmaps provide evidence-based recommendations from a task force of experts. Perspectives, Comment, Clinical Outlook and News & Views articles carry topical discussion, and Research Highlights filter primary research from cardiovascular and general medical journals.体裁： 深度叙述性综述提供某一主题的权威且与时俱进的介绍，并把它放在该领域的历史与演进脉络中加以定位；共识声明、循证指南、专家建议与路线图由专家组给出循证推荐；观点、评论、临床展望与新闻与观点刊发话题性讨论，研究亮点则从心血管与综合医学刊物中筛选一级研究；
• Commissioned model: articles written by external authors are invited or commissioned by the in-house editors, and authors may submit proposals for Review-type and Comment-type articles which the editors may formally commission. Complete unsolicited manuscripts are therefore not accepted.约稿定位： 外部作者撰写的文章由编辑部邀请或约稿，作者可提交综述类与评论类的选题提案并由编辑部决定是否正式约稿，因此期刊不接受直接投来的完整稿件；
• Open access: articles can only be published using the subscription route, and the publisher offers no immediate gold open access option and charges no publication fee. Six months after online publication, authors may self-archive the accepted manuscript on their personal website or in a funder or institutional repository.开放获取： 文章只能按订阅方式出版，出版方不提供立即开放获取选项，也不收取版面费；作者可在文章在线发表六个月后，将已接受的稿件存入个人主页或资助方与所属机构的知识库；

History

• 2004: the title was founded as Nature Clinical Practice Cardiovascular Medicine, one of eight new clinical journals introduced by Nature Publishing Group, several of which carried the endorsement of prestigious societies and organizations.2004年： 刊物以 Nature Clinical Practice Cardiovascular Medicine 之名创刊，属当时自然出版集团新推的八本临床类刊物之一，这批刊物多获权威学会与组织的认可背书。
• January 2009: the publisher announced that from April of that year the eight clinical journals would be rebranded as Nature Reviews, expanding the series from seven titles to fifteen, alongside a switch to full-colour printing and redesigned websites that added roughly a quarter more content to each issue.2009年1月： 出版方发布公告，宣布自当年 4 月起把八本临床类刊物统一改冠 Nature Reviews 品牌，系列规模由七本扩至十五本，改名同时改用全彩印刷并重新设计网站，每期内容增加约四分之一。
• April 2009: the title became Nature Reviews Cardiology as part of the Nature Reviews brand, and the publisher stated that the rebrand would leave the editorial scopes and commissioning strategies of these journals unchanged.2009年4月： 刊物正式改名为 Nature Reviews Cardiology，成为 Nature Reviews 品牌下的一员；出版方同时说明这批刊物不改变编辑范围与约稿策略。
• Change of leadership: Gregory Lim joined as an Associate Editor in 2011, was promoted through Senior Editor, and became Chief Editor in August 2015, by which time the journal already led its category in the Cardiac & Cardiovascular Systems by impact factor.主编更替： Gregory Lim 于 2011 年以副编辑身份加入本刊，其后依次升任高级编辑并于 2015 年 8 月出任主编，接手时该刊在心脏与心血管系统类目中的影响因子已居于首位。
• New formats: beyond Reviews and Perspectives the journal added Consensus Statements, Evidence-based Guidelines and Clinical Outlook, and it groups articles into collections on themes such as cardiovascular disease in women, underscoring its bridging position between clinical practice and translational research.体裁扩充： 期刊在常规综述与观点之外增设共识声明、循证指南与临床展望等体裁，并围绕女性心血管疾病等专题组织专辑，凸显其在临床实践与转化研究之间的桥接定位。^[2]

Editors

• Chief Editor: the journal is led by Gregory Lim DPhil, who took a first class BA in physiological sciences at the University of Oxford and then completed a DPhil in cardiovascular medicine on the role of nitric oxide in modulating cardiac contractility. He joined the journal in 2011 and has been Chief Editor since August 2015, based in the London office.主编： 现任主编为 Gregory Lim 博士，他在牛津大学取得生理学科学学士学位并以一氧化氮调控心脏收缩性的课题完成心血管医学博士学位研究，2011 年加入本刊，2015 年 8 月起出任主编，常驻伦敦办公室。
• Senior Editors: Karina Huynh PhD and Irene Fernández Ruiz PhD serve as Senior Editors, based in Melbourne and Madrid respectively, and handle commissioning across different specialty areas.高级编辑： Karina Huynh 博士（驻墨尔本）与高级编辑（Irene Fernández Ruiz，驻马德里）分别承担不同专科方向的选题与约稿工作。
• Cross-journal team: a Reviews Cross-Journal Editorial Team also works across the Nature Reviews portfolio as needs arise, handling content in the life, clinical, physical and social sciences for this and other titles in the series.跨刊团队： 期刊另设跨刊综述编辑团队，在需要时于生命、临床、物理与社会科学各领域之间调配人手，承接本刊及同系列其他刊物的选题。
• Submissions and contact: manuscripts and proposals are submitted through the Nature Publishing Group online submission and tracking system, and general editorial inquiries are addressed to the editorial team.投稿与联系： 稿件与选题提案通过自然出版集团的在线投稿与追踪系统提交，一般编辑问询由编辑部统一受理。
• Access options: the journal is offered to both individual and institutional subscribers, with institutions able to purchase online access through the group's licensing channels, and individual subscriptions available either online only or in print and online.读者服务： 期刊同时面向个人订户与机构订户发行，机构可通过集团授权渠道购买在线访问权限，个人订阅则提供在线版或纸质加在线版两种选择。^[3]